TP53 and breast cancer: In addition to all these evidences, Chen and Wong found that selenocystine treatment increased MCF-7 breast cancer cells apoptosis by modulation of ERK and Akt phosphorylation or with the involvement of p53 phosphorylation and ROS generation [29,30], supporting the results obtained in this study.